We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Prognostic Panel Helps Identify Lupus Patients at Risk for Kidney, Brain, or Cardiovascular Involvement

By LabMedica International staff writers
Posted on 24 Jun 2014
Print article
In response to physician requests to help fulfill an unmet need, the new prognostic test helps assess potential risk of various Lupus related complications.

Lupus patients can suffer from disease flares that can become destructive to any organ or tissue in the body. Exagen Diagnostics, Inc. (Albuquerque, NM, USA), a leading diagnostics development company focused in rheumatology, has launched the addition of "Avise SLE Prognostic" to its testing services. Designed to supplement the "Avise SLE+ Connective Tissue" diagnostic, the Avise SLE Prognostic panel helps physicians assess potential risk for lupus nephritis, neuropsychiatric SLE (Systemic lupus erythematosus), thrombosis, and cardiovascular events.

The prognostic panel was developed in response to physician requests to help fulfill an unmet need in the rheumatology space. The panel includes the following markers: anti-C1q – prognostic factor for lupus nephritis; anti-Ribosomal P – prognostic factor for neuropsychiatric SLE; and anti-phosphatidylserine/prothrombin (PS/PT) (IgM, IgG) – prognostic factor for thrombosis in SLE. Also, prognostic factors for thrombosis and cardiovascular events – anti-cardiolipin (IgM, IgG, IgA) and anti-β2-Glycoprotein 1 (IgM, IgG, IgA) – are indirectly included in the Avise SLE+ Connective Tissue 2.0 diagnostic or as an add-on to Avise SLE 2.0.

Complimenting Avise SLE 2.0 or Avise SLE+ Connective Tissue 2.0, Avise SLE Prognostic uses the same blood draw specimen as for the diagnostic and offers pre-provided kits, pre-paid Fedex, limited patient out-of-pocket cost, and high quality data based results within 7 days.

"We are pleased to provide an additional tool to help support physicians with their clinical assessment and treatment of patients. This launch furthers our commitment to providing access to quality serologic testing to all patients," said Ron Rocca, Exagen President and CEO.

Related Links:
Exagen Diagnostics
Avise Tests


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.